| Trial ID: | L1034 |
| Source ID: | NCT01442272
|
| Associated Drug: |
Hidroferol®
|
| Title: |
Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
|
| Acronym: |
NEFROVID2010
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic|Disorder of Vitamin D
|
| Interventions: |
DRUG: Hidroferol®|DRUG: Paricalcitol: Zemplar®|DRUG: Habitual medication
|
| Outcome Measures: |
Primary: Protein/creatinine quotient and albumin/creatinine in matinal urine sample: basal and 3 period months after a month of the therapeutic protocol beginning., 1-3 month |
|
| Sponsor/Collaborators: |
Sponsor: Hospital Universitario de Canarias
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
174
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2013-10
|
| Results First Posted: |
|
| Last Update Posted: |
2012-05-21
|
| Locations: |
Hospital Universitario de Canarias, La Laguna, S/C Tenerife, 38320, Spain|HUC, La Laguna, S/c Tenerife, 38320, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT01442272
|
